23rd Annual Liver Disease Wrap-Up (On-Demand)
To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.
This activity was recorded live during the 23rd Annual Liver Disease Wrap-up held December 12, 2020.
Educational Planning Team
- Educational Planner - Robert J Fontana, MD
- Co-Planner - Anna Suk-Fong Lok, MD
- Activity Coordinators - Allison Picinotti, Erin Reau, Emily Vandervoort
- Patricia P Bloom, MD
- Robert J Fontana, MD
- Anna Suk-Fong Lok, MD
- Jessica L Mellinger, MD, PhD, MSc
- Elliot B Tapper, MD
There are no relevant financial relationships to disclose for this activity.
- identify the latest developments in the diagnosis and treatment of chronic hepatitis B and C.
- implement management of patients with cirrhosis and autoimmune liver injury.
- identify and treat manifestations and complications of portal hypertension in patients withcirrhosis including bleeding, ascites and hepatic encephalopathy.
The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Michigan Medical School designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 Medical Knowledge MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to the ACCME for the purpose of granting ABIM MOC credit.
Louvet A, et al Hepatology 2017;66(5)
Bertolotti M, et al Hepatology 1997
Aberg F, et al Hepatology 2018